TargetRx to Shape Discussion at Pharmaceutical Leadership Forum

CEO Mike Luby to Discuss How Predictive Sales & Marketing Information Can be Utilized to Drive Brand Performance and Increase Market Share

Horsham, PA - November 1, 2005 - TargetRx, a pharmaceutical marketing information services company that delivers actionable insights to improve brand performance, today announced that CEO Mike Luby will be presenting at the upcoming Pharmaceutical Leadership Forum to be held November 7-8th, 2005 at the Ritz-Carlton in Washington D.C.

This year's show, entitled "Architects of Change: Positioning for Profitability, Sustainability and Stakeholder Confidence," aims to explore different pressures facing the pharmaceutical industry and how business models are changing as a result, covering long-term implications for the pharmaceutical industry and what this means for service providers supporting the pharmaceutical industry.

Luby will be participating in a panel discussion, "The Implications of the Changing Dynamics of the Pharmaceutical Industry: Service Provider Perspectives Panel," to be held Monday, November 7th from 11:45 a.m. to 12:30 p.m. Luby will discuss how pharmaceutical companies can utilize predictive marketing information on emerging trends and physician prescribing patterns to improve sales and marketing effectiveness, increase brand equity, and improve sales performance.

"It's no secret that the pharmaceutical industry is rethinking its entire sales and marketing model," said Luby. "With better information to predict brand performance and identify emerging trends, pharmaceutical companies will be better equipped to know where to focus their sales and marketing strategies for their best return in the marketplace. This is what TargetRx is dedicated to helping its clients achieve, and we see great opportunity in the current environment."

As Founder and CEO of TargetRx, Luby brings more than 15 years of pharmaceutical marketing and sales experience from a variety of therapeutic areas. Under Luby's leadership since being founded in 1999, TargetRx has succeeded in raising over $50 million in capital, expanding its team to more than 110 employees, and securing clients in the majority of the top 30 pharmaceutical companies worldwide. Luby is also the lead author on TargetRx's patent-pending method of analyzing the effectiveness of marketing and sales strategies. Prior to forming TargetRx, Luby spent 10 years at Merck & Co., Inc., where he created and executed marketing strategies for both the specialty and mass markets. The concept for TargetRx was born from his dissatisfaction with the lack of insightful, predictive and actionable marketing information from external sources during his tenure at Merck.

About TargetRx

TargetRx provides pharmaceutical and biotech companies with unique insight into the true drivers of product choice and adoption for their brands, helping clients to confidently take the actions that will grow their businesses and help patients. Serving the majority of the top 30 pharmaceutical and biotech companies, TargetRx enables clients to significantly improve the launch of new products and indications, physician segmentation and targeting, creation of professional messaging and materials, and sales and marketing execution and effectiveness. All TargetRx solutions are powered by our AdvantageBuilderSM normative database and validated predictive models, created from capturing in-depth physician attitudes on the "four forces" of prescribing - product, payor, promotion and patient - on new launches, marketing campaigns and physician-rep interactions on over 500 pipeline and inline brands and modeling these attitudes against actual prescribing behavior. For more information, visit www.targetrx.com.

Media Contact:

Joe Ford
Phone: 215-444-8722
jford@targetrx.com